Align Technology, Inc. ( ALGN) - Key Metrics
ALGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $14.78 | $1.52 | $2.70 | $3.13 |
| 2026Q1 | $14.56 | $1.58 | $2.11 | $1.68 |
| 2025Q4 | $14.61 | $1.89 | $3.11 | $4.04 |
| 2025Q3 | $13.76 | $0.78 | $2.61 | $1.69 |
| 2025Q2 | $13.95 | $1.72 | $1.77 | $2.12 |
ALGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 27.92 |
| 2026Q1 | 0% | 27.13 |
| 2025Q4 | 0% | 20.65 |
| 2025Q3 | 0% | 40.13 |
| 2025Q2 | 0% | 27.52 |
ALGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.85% | 0% |
| 2026Q1 | 0.98% | 0% |
| 2025Q4 | 2.59% | 0% |
| 2025Q3 | 1.35% | 0% |
| 2025Q2 | 1.12% | 0% |
ALGN
Price: $145
52 week price:
Earnings Per Share: 5.77 USD
P/E Ratio: 30.03
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 998484
Ebitda: 109.6 millionMarket Capitalization: 11.4 billion